Doctors Without Borders - MSF APAC 36d ago

Since June 2025, Doctors Without Borders has been using PANAF, a WHO pre-approved antivenom, to treat snakebite patients. In this interview, Dr Kassaw explains how MSF is assessing the efficacy of PANAF and why the findings matter for patient care. The results of the study will be presented to authorities and relevant stakeholders in June 2026. #DoctorsWithoutBorders #MSF #Snakebite #Antivenom #PANAF #GlobalHealth #MedicalHumanitarian #NeglectedDiseases Follow us: Facebook: https://facebook.com/doctorswithoutborders.apac Instagram: https://instagram.com/doctorswithoutborders.apac/ Twitter: https://twitter.com/MSF_APAC LinkedIn: https://www.linkedin.com/company/doctorswithoutborders-apac Website: https://doctorswithoutborders-apac.org/